Covestor LTD Corcept Therapeutics Inc Transaction History

Covestor LTD

$150 Million
Q1 2025

A detailed history of Covestor LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Covestor LTD holds 626 shares of CORT stock, worth $42,693. This represents 0.05% of its overall portfolio holdings.

Number of Shares

626

Previous 34 1741.18%

Holding current value

$42,693

Previous $2,000 3500.0%

% of portfolio

0.05%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$49.85 - $114.22 $29,511 - $67,618	592 Added 1741.18%	626 $72,000
Q4 2024 Feb 13, 2025	SELL	$44.66 - $60.85 $13,799 - $18,802	-309 Reduced 90.09%	34 $2,000
Q3 2024 Nov 01, 2024	BUY	$29.51 - $46.26 $501 - $786	17 Added 5.21%	343 $16,000
Q2 2024 Aug 09, 2024	SELL	$22.21 - $34.48 $104,009 - $161,469	-4,683 Reduced 93.49%	326 $10,000
Q1 2024 May 10, 2024	BUY	$21.1 - $27.46 $25,678 - $33,418	1,217 Added 32.09%	5,009 $126,000
Q4 2023 Feb 09, 2024	SELL	$24.82 - $32.88 $26,706 - $35,378	-1,076 Reduced 22.1%	3,792 $123,000
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $1,120 - $1,723	-51 Reduced 1.04%	4,868 $133,000
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $63,891 - $74,947	2,980 Added 153.69%	4,919 $109,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $8,985 - $11,451	468 Added 31.82%	1,939 $42,000
Q4 2022 Feb 13, 2023	SELL	$19.95 - $29.96 $59 - $89	-3 Reduced 0.2%	1,471 $29,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $35,790 - $42,194	1,449 Added 5796.0%	1,474 $38,000
Q2 2022 Aug 10, 2022	SELL	$17.33 - $25.3 $1,403 - $2,049	-81 Reduced 76.42%	25 $1,000
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $595 - $907	36 Added 51.43%	106 $2,000
Q4 2021 Feb 10, 2022	BUY	$17.1 - $23.34 $1,197 - $1,633	70 New	70 $1,000

Others Institutions Holding CORT

# of Institutions

472

Shares Held

84.3M

Call Options Held

1.43M

Put Options Held

2.75M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account